Viewing Study NCT05575518


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2025-12-26 @ 3:51 AM
Study NCT ID: NCT05575518
Status: RECRUITING
Last Update Posted: 2023-08-25
First Post: 2022-10-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
Sponsor: Stellah Mpagama
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module